Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Journal of Southern Medical University ; (12): 32-35, 2009.
Article in Chinese | WPRIM | ID: wpr-339073

ABSTRACT

<p><b>OBJECTIVE</b>To identify the differentially expressed proteins in the serum of patients with cervical cancer for use as the biomarkers for early diagnosis of cervical cancer.</p><p><b>METHODS</b>Surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) with weak cationic chips (CM10) was used to examine the serum samples of 24 patients with cervical squamous cell carcinoma and 25 age-matched healthy women. The protein fingerprints were obtained, and bioinformatic analysis was performed to identify the differentially expressed proteins in the serum of the patients.</p><p><b>RESULTS</b>Fifty-two differentially expressed proteins were detected in the serum of cervical cancer patients (P<10(-5)), among which 6 proteins with mass/charge ratio of 4173.77, 5903.09, 6087.12, 10716.9, 6109.61 and 3397.41, respectively, showed lowered expression in the serum of cervical cancer patients. Two diagnostic models for cervical cancer were generated using software, including one consisting of the 4173.77(M/Z) protein with the diagnostic specificity of 96% and sensitivity of 75% for cervical cancer and the other consisting of 3 proteins at 5335.81(M/Z), 7562.99(M/Z), and 9287.89(M/Z) with specificity of 91.67% and sensitivity of 96.0%.</p><p><b>CONCLUSION</b>Cervical cancer patients show different serum protein expression profile from healthy women. The 6 differential proteins identified may serve as specific serum biomarkers in close relation to the origin and progression of cervical cancer.</p>


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Biomarkers, Tumor , Blood , Blood Proteins , Carcinoma, Squamous Cell , Blood , Diagnosis , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Methods , Uterine Cervical Neoplasms , Blood , Diagnosis
2.
Journal of Southern Medical University ; (12): 1241-1243, 2007.
Article in Chinese | WPRIM | ID: wpr-283161

ABSTRACT

<p><b>OBJECTIVE</b>To explore the inhibitory effect of garlic oil on cyclin E expression in gastric adenocarcinoma cells.</p><p><b>METHODS</b>Human gastric adenocarcinoma SGC7901 cells were cultured routinely and the expressions of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) are detected by immunofluorescent staining and flow cytometry. The SGC7901 cells were also cultured with RPMI 1640 without calf serum for 48 h, followed by further culture with RPMI 1640 in the presence of 2.5% calf serum before treatment with TGFalpha, garlic oil, or their combination, and cyclin E expression of the cells was then detected by immunofluorescent staining and flow cytometry.</p><p><b>RESULTS</b>The positivity rates of TGFalpha and EGFR expressions were 46.80% and 57.78 % respectively in SGC7901 cells cultured routinely for 48 h. The positivity rate of cyclin E expression was increased by 7.06% (P<0.001) in SGC7901 cells treated with 30 microg/L TGFalpha for 5 h, decreased by 11.75% (P<0.001) following a 5-hour treatment with 10% garlic oil, and decreased further by 17.11% (Plt;0.001) after treatment with both 30 microg/L TGFalpha and 10% garlic oil for 5 h.</p><p><b>CONCLUSIONS</b>The gastric adenocarcinoma SGC7901 cells express TGFalpha and EGFR and possess TGFalpha autocrine and paracrine loops to promote cell proliferation. Garlic oil inhibits cyclin E expression in routinely cultured SGC7901 cells and also in TGFalpha-treated ones, suggesting that garlic oil can inhibit the TGFalpha autocrine and paracrine loops, which can be one of the pathways of garlic oil to inhibit cancer cell proliferation.</p>


Subject(s)
Animals , Humans , Adenocarcinoma , Genetics , Pathology , Allyl Compounds , Pharmacology , Antineoplastic Agents , Pharmacology , Cell Line, Tumor , Cyclin E , Metabolism , Down-Regulation , Gene Expression Regulation, Neoplastic , ErbB Receptors , Metabolism , Stomach Neoplasms , Genetics , Pathology , Sulfides , Pharmacology , Transforming Growth Factor alpha , Metabolism
3.
Journal of Southern Medical University ; (12): 1444-1446, 2007.
Article in Chinese | WPRIM | ID: wpr-283110

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the effects of topical DMSO and intralesional hyaluronidase administration, used alone or in combination, on skin injury due to vinorelbine extravasation in rats.</p><p><b>METHODS</b>Skin injury due to vinorelbine extravasation was induced in the lower extremities of 30 SD rats, which were treated subsequently with topical DMSO, intralesional hyaluronidase, their combination, topical saline, and intralesional saline, with the rats without any treatment as the control. The wound area on 1, 4, 8, 12, 18, 24, 30 days and the time of healing were observed and compared.</p><p><b>RESULTS</b>The wound area on 1, 4, 8, 12, 18, and 24 days were significantly smaller in topical DMSO group than in topical saline and control groups (P<0.05), and so in intralesional hyaluronidase group than in intralesional saline and control groups (P<0.05), but there was no significant difference between single agent (hyaluronidase and DMSO) treatment group and the combined treatment group. The healing time was significantly shorter in topical DMSO and intralesional hyaluronidase groups than in topical and intralesional saline groups and control group ( 24.9-/+3.2 and 21.9-/+3.0 days vs 29.8-/+2.6, 28.6-/+4.1 and 30.6-/+3.0 days, P<0.01), but comparable between the two single agent groups and combined treatment group (23.3-/+3.8 days).</p><p><b>CONCLUSION</b>Intralesional hyaluronidase and topical DMSO application are effective therapies for skin damage due to vinorelbine extravasation, and their combination does not improve the therapeutic effect.</p>


Subject(s)
Animals , Female , Male , Rats , Administration, Topical , Dimethyl Sulfoxide , Pharmacology , Drug Therapy, Combination , Hyaluronoglucosaminidase , Pharmacology , Injections, Intralesional , Skin , Wounds and Injuries , Pathology , Time Factors , Vinblastine , Pharmacology , Wound Healing
4.
Journal of Southern Medical University ; (12): 1255-1257, 2006.
Article in Chinese | WPRIM | ID: wpr-334948

ABSTRACT

<p><b>OBJECTIVE</b>To explore the effect of transforming growth factor alpha (TGFalpha) on the expression of cyclin E and D1 in gastric carcinoma cells.</p><p><b>METHODS</b>Human gastric adenocarcinoma SGC7901 cells were cultured routinely and synchronized at G(0)/G(1) phase in serum-free RPMI-1640. The percentage of the cells at G(0)/G(1) phase was detected by propidium iodide staining and flow cytometry (FCM), and the synchronized cells were cultured in RPMI-1640 supplemented with 2.5% calf serum and treated with 10, 30, and 50 microg/L TGFalpha for 5 h. The expression of cyclin E and D1 in SGC7901 cells was detected by immunofluorescent staining and FCM.</p><p><b>RESULTS</b>The percentage of the cells at G(0)/G(1) phase increased from 54% in routine culture to 72% in the serum-free RPMI-1640 culture. TGFalpha treatment of the cells synchronized at G(0)/G(1) phase induced significant increment of cyclin E and D1 expressions (P<0.001), and at the dose of TGFalpha of 50 microg/L, their expressions increased by 25.18% and 27.52%, respectively (P<0.001).</p><p><b>CONCLUSION</b>TGFalpha can increase the expression of cyclin E and D1 in gastric carcinoma cells to promote their cell cycle progress.</p>


Subject(s)
Humans , Adenocarcinoma , Metabolism , Pathology , Cell Cycle , Cell Line, Tumor , Cyclin D1 , Cyclin E , Flow Cytometry , Fluorescent Antibody Technique , Stomach Neoplasms , Metabolism , Pathology , Transforming Growth Factor alpha , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL